Friday, March 24, 2017
Neurotrope's President and Chief Scientific Officer to Present Keynote Address at Sachs Associates' 2nd Annual Neuroscience Biopartnering & Investment Forum
NEW YORK, March 24, 2017 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer' s disease, announced that Dr. Daniel Alkon, M.D., Neurotrope's President and Chief Scientific Officer, is scheduled to present at t.....

Global Tissue Transglutaminase Test Market Set to Surge Significantly by 2027
Market Highlights:

Globally the market for Tissue Transglutaminase Test is increasing rapidly and the main reason f...
The American College of Medical Genetics and Genomics (ACMG) Announces New Board Members and President-elect
BETHESDA, Md., March 24, 2017 /PRNewswire-USNewswire/ -- During the 2017 ACMG Annual Clinical Genetics Meeting in Phoenix, Arizona, the American College of Medical Genetics and Genomics welcomed four new directors to its Board. As new Board members, they will serve as advocates for the organiz.....
Published Outcomes Results from SEER Registries Indicates That Many Node-positive Breast Cancer Patients Can Avoid Chemotherapy Based on Oncotype DX® Results
REDWOOD CITY, Calif., March 24, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of results from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Registry in the peer-reviewed journal


About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines